Watchful Waiting

• 

  Subject Areas on Research

  • ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. 
  • ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update. 
  • Active Surveillance Versus Nephron-Sparing Surgery for a Bosniak IIF or III Renal Cyst: A Cost-Effectiveness Analysis. 
  • Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men. 
  • Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC). 
  • Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). 
  • Adhesive Small Bowel Obstruction: Early Operative versus Observational Management. 
  • African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. 
  • An Internet intervention for management of uncertainty during active surveillance for prostate cancer. 
  • Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer. 
  • Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. 
  • Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer. 
  • Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer. 
  • Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance. 
  • Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. 
  • Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database. 
  • Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience. 
  • Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments. 
  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. 
  • Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer. 
  • Considerations for Management of Head and Neck Lymphatic Malformations in Children. 
  • Counterpoint: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer? 
  • Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia. 
  • Ductal Carcinoma In Situ Biology, Language, and Active Surveillance: A Survey of Breast Radiologists' Knowledge and Opinions. 
  • Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms. 
  • Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. 
  • Estimating the magnitude of clinical benefit of local therapy in patients with DCIS. 
  • Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer. 
  • Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance. 
  • Health resource utilization of labor induction versus expectant management. 
  • High-Suspicion Subcentimeter Thyroid Nodules: Cost Effectiveness of Active Surveillance versus Fine Needle Aspiration. 
  • Hodgkin lymphoma. 
  • How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? 
  • Hypertension in pregnancy and adverse outcomes among low-risk nulliparous women expectantly managed at or after 39 weeks: a secondary analysis of a randomised controlled trial. 
  • Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ. 
  • Immediate laparoscopic adrenalectomy versus observation: cost evaluation for incidental adrenal lesions with atypical imaging characteristics. 
  • Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer. 
  • Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation. 
  • Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. 
  • Low-risk and very-low-risk prostate cancer: is there a role for focal therapy in the era of active surveillance? Yes, the two approaches complement each other. 
  • Management of Functional Esophagogastric Junction Outflow Obstruction: A Systematic Review. 
  • Management of Locoregional Rectal Cancer. 
  • Management of hepatocellular adenoma: comparison of resection, embolization and observation. 
  • Maternal Morbidity After Previable Prelabor Rupture of Membranes. 
  • Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients. 
  • Maximizing outcomes in genitourinary cancers across the treatment continuum. 
  • Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance. 
  • Multi-faceted strategies improve collection compliance and sample acceptance rate for carbapenem-resistant Enterobacteriaceae (CRE) active surveillance testing. 
  • Multifactor Influences of Shared Decision-Making in Acoustic Neuroma Treatment. 
  • Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. 
  • Nonoperative management of rectal cancer. 
  • Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. 
  • Operating in the Dark: When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis? 
  • Operative Versus Nonoperative Treatment for Adult Symptomatic Lumbar Scoliosis. 
  • Operative resection is currently overutilized for cystic lesions of the pancreas. 
  • Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis. 
  • Outcomes and complications related to the management of Bosniak cystic renal lesions. 
  • Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis. 
  • Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance. 
  • Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance. 
  • Patient outcomes in the operative and nonoperative management of high-grade spondylolisthesis in children. 
  • Pediatric Traumatic Brain Injury: Families and Healthcare Team Interaction Trajectories During Acute Hospitalization. 
  • Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. 
  • Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance). 
  • Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. 
  • Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer? 
  • Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer. 
  • Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance. 
  • Preventing Hospitalization in Mild Acute Pancreatitis Using a Clinical Pathway in the Emergency Department. 
  • Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis. 
  • Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance. 
  • Psychosocial aspects of active surveillance. 
  • Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center. 
  • Radical prostatectomy versus observation for localized prostate cancer. 
  • Randomized clinical trial of an emergency department observation syncope protocol versus routine inpatient admission. 
  • Rare cases of large parapharyngeal lipomas. 
  • Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Red flag screening for low back pain: nothing to see here, move along: a narrative review. 
  • Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - An alternative template for prostate fusion biopsy. 
  • Refining Angular Pregnancy Diagnosis in the First Trimester: A Case Series of Expectant Management. 
  • Rituximab for follicular lymphoma: watch and wait, watch and worry, or watch and live? 
  • Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value. 
  • Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density. 
  • Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. 
  • Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer. 
  • Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? 
  • Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer. 
  • The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). 
  • The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer. 
  • The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer. 
  • The effect of watchful waiting on the management and treatment of inguinal hernias in a community setting. 
  • Utility of observation units for young emergency department chest pain patients. 
  • Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. 
  • Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ. 
  • eComment. Persistent type 2 endoleaks after endovascular aneurysm repair: why and when to intervene?